Skip to main content

Table 2 Genetic diversity of P. vivax in patient blood samples (P) and oocysts (O) for six selected cases

From: Plasmodium vivax genetic diversity and heterozygosity in blood samples and resulting oocysts at the Thai–Myanmar border

Measure

Infection

Sample

N

Locus

Mean

SE

Pv3.27

Pv3.502

Pv8.504

MS5

MS6

MS7

MS8

MS16

Number of alleles

Monoclonal

P

3

3

3

2

2

3

3

3

3

2.750

0.164

O

97

4

3

2

2

3

3

3

3

2.875

0.227

Polyclonal

P

3

4

3

2

3

3

2

4

3

3.000

0.267

O

34

5

5

4

2

6

4

6

4

4.500

0.463

All oocysts

 

131

7

6

5

5

6

6

8

6

6.125

0.927

Expected heterozygosity

Monoclonal

P

3

0.667

0.667

0.444

0.444

0.667

0.667

0.667

0.667

0.611

0.036

O

97

0.290

0.187

0.177

0.069

0.360

0.078

0.159

0.119

0.180

0.036

Polyclonal

P

3

0.722

0.667

0.278

0.667

0.667

0.444

0.722

0.611

0.597

0.055

O

34

0.757

0.698

0.653

0.346

0.707

0.597

0.704

0.656

0.640

0.045

All oocysts

 

131

0.527

0.354

0.436

0.301

0.474

0.406

0.433

0.492

0.428

0.069

  1. Monoclonal and polyclonal infections are defined by initial blood stage results (see main text and Fig. 2)